PIONEERINGCOLLECTIVE

Company

Share this profile

Resume
Eli Lilly & Co.'s weight loss drug Zepbound’s approval by the Food and Drug Administration introduces a cheaper option to a growing market, increasing the pressure
Social Network

  last updated on